Skip to main content
. 2019 Jun 18;12(9):1177–1184. doi: 10.1016/j.tranon.2019.05.004

Figure 2.

Figure 2

Changes in SR, as monitored during and at the completion of neoadjuvant chemotherapy. (A) SRs for pathologically complete responders (RS5) and non–pathologically complete responders (RS1-4). Corresponding representative mastectomies (not shown) of responders and nonresponders demonstrate differences in the overall tumor morphology between response groups. (B) SRs for tumors with response scores 4-5, representing responders, and response scores 1-3, representing nonresponders. (C) SRs for tumors with response scores 3-5, representing responders, and response scores 1-2, representing nonresponders. * indicates statistical significance (P < .05) and ** indicates statistical significance (P < .001).